15
Views
9
CrossRef citations to date
0
Altmetric
Review

Current approaches to CNS tumors in infants and very young children

&
Pages 681-690 | Published online: 10 Jan 2014

References

  • Centers for Disease Control. United States Cancer Statistics: 2000 Incidence Report (2000).
  • Cavalheiro S, Moron A, Hisaba W, Dastoli P, Silva N. Fetal brain tumors. Child Nerv. Syst. 19, 529–536 (2003).
  • Mazewski C, Hudgins R, Reisner A, Geyer J. Neonatal brain tumors: a review. Sem. Perinatology 23, 286–298 (1999).
  • Lin Y-C. Early recognition of infant malignancy: the five most common infant cancers. Neonatal Network 22, 11–19 (2003).
  • Sato Y. Pediatric primary brain tumors. Top. Magn. Reson. Imag. 4, 64–77 (1992).
  • Rosenblum M, Matsutani M, Van Meir E. CNS germ cell tumors. Turn. Nerv. Syst. 208 (2000).
  • Brown K, Mapstone T, Oakes WA. Modem analysis of intracranial tumors of infancy. Pediatr Neumsurg. 26, 25–32 (1997).
  • Gurney J, Smith M, Ross J. Cancer among infants. Cancer Incidence and Survival Among Children and Adolescents: United States SEER program (1975–1995). National Institutes of Health Bethesda, MD, USA, 149–156 (1999).
  • Jenkin D, Danjoux C, Greenberg M. Subsequent quality of life for children irradiated for a brain tumor before age 4 years. Med. Pediatc Oncol 31,506–511 (1998).
  • Duffner P, Cohen M, Thomas P Late effects of treatment on the intelligence of children with posterior fossa tumours. Cancer51, 233–237 (1983).
  • Spunburg J, Chang C, Goldman M. Quality of long-term survival following irradiation for intracranial tumors in children under the age of two. Int. Radiat. Oncol Biol. Phj. 7, 727–736 (1981).
  • Ellenberg L, McComb J, Siegel S, Stowe S. Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21,638–644 (1987).
  • Duffner P, Cohen M. Changes in the approach to central nervous system tumors in childhood. Pediatric Clin. N Am. 39, 859–876 (1992). Pivitol paper describing the change in approach to childhood tumors, taking into account long-term effects.
  • Pollack I. Pediatric brain tumors. Sem. Surg. Oncol 16,73–90 (1999).
  • Miralbell R, Lomax A, Bortfeld T et al. Potential role of proton therapy in the treatment of pediatric medulloblastoma/ primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int. J Radiat. Oncol Biol. Phj. 38, 477–484 (1997).
  • Grill J, Kieffer Renaux V, Bulteau C et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int. J Radiat. Oncol Riol Phys. 45,137–145 (1999).
  • Mulhern R, Kepner J, Thomas P et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced—dose craniospinal irradiation: a Pediatric Oncology Group Study. J Clin. Oncol 16, 1723–1728 (1998).
  • Geyer J. Infant brain tumors. Neurosurg. Clin. N Am. 3,781–789 (1992).
  • Goldwein J, Leahy J, Packer R et al Intracranial ependymomas in children. Int. I Radiat. Oncol Biol. Phys. 19,1497–1502 (1990).
  • Merchant T, Haida T, Wang M—H et al Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J. Neurosurg. 86,943–949 (1997).
  • Merchant T, Zhu Y, Thompson S et al. Preliminary results from a Phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and ependymoma. mt. J Radiat. Oncol Biol. Phys. 52,325–332 (2002).
  • Hodgson D, Goumnerova L, Loeffler J et al Radiosurgery in the management of pediatric brain tumors. Int. J Radiat. Oncol Biol. Phys. 50,929–935 (2001).
  • Sposto R, Ertel I, Jenkin R etal. The effectiveness of chemotherapy for treatment of high-grade astrocytoma in children: results of a randomized trial. A report from the Children's Cancer Study Group. J. Neuro—Oncol. 7,165-177 (1989).
  • Baram T, van Eys J, Dowell R et al Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy: a preliminary report. Cancer 60,173–177 (1987).
  • Duffner P, Horowitz M, Krischer J et al Postoperative chemotherapy and delayed radiation in children less than 3 years of age with malignant brain tumors. N Engl Med. 328,1725–1731 (1993).
  • Gururangan S, Dunkel I, Goldman S et al Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin. Oncol 16,2486–2493 (1998).
  • Mason W, Grovas A, Halpern S et al Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin. Oncol 16,210–221 (1998).
  • Sands S, van Gorp W, Finlay J. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Child. Net-v. Syst. 14,587–589 (1998).
  • Heideman R, Packer R, Albright L et al Tumors of the central nervous system. In: Principles and Practice of Pediatric Oncology Pizzo P, Poplack D (Eds). Lippincott, PA, USA, 505–544 (1989).
  • Packer R, Ater J, Allen J et al Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. Neurosurg. 86,747–754 (1997).
  • Wisoff J, Boyett J, Berger M et al Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood; a report of the Children's Cancer Group Trial No CCG-945. I Neurosurg. 89,52–59 (1998).
  • Campbell J, Pollack I, Martinez A, Shulz B. High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neumsurgeiy38, 258–264 (1996).
  • Duffner P, Krischer J, Burger P et al Treatment of infants with malignant gliomas: the Pediatric Oncology Group Experience. J. Neuro—Oncol 28,245–256 (1996).
  • Finlay J, Goldman S, Wong M et al Pilot study of high dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group." Clin. Oncol 14,2495–2503 (1996).
  • Pollack I, Claassen D, al—Shboul Q et al Low grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J. Neurosurg. 82,536-547 (1995).
  • Capelli C, Grill J, Raquin M et al. Long- term follow-up of 69 patients treated for optic pathway tumors before the chemotherapy era. Arch. Dis. Child. 79, 334–338 (1998).
  • Grill J, Couanet D, Cappelli C et al Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann. Neural. 45,393–396 (1999).
  • Lacaze E, Kieffer V, Streri A et al Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br. J. Cancer 89,2038–2044 (2003).
  • Laithier V, Grill J, Le Deley M-C et al Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy — results of the first French prospective study for the French society of pediatric oncology. J. Clin. Oncol 21, 4572–4578 (2003).
  • Albright A, Wisoff J, Zeltzer P et al Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. J. Neurosurg. 38,265–271 (1996).
  • Packer R, Finlay J. Chemotherapy for childhood medulloblastoma and primitive neuroectodermal tumors. Oncologist l, 381–393 (1996).
  • Bailey C, Gnekow A, Wellek S et al. Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma: International Society of Paediatric Oncology (SOP) and the (German) Society of Paediatric Oncology (GOP). STOP II. Med. PetBah: Oncol. 25, 166–178 (1995).
  • Goldwein J, Radcliffe J, Johnson J et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int. J. Radiat. Oncol. Biol. Phys. 34, 899–904 (1996).
  • Thomas P, Deutsch M, Kepner J et al Low—stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J. Clin. Oncol. 18, 3004–3011 (2000). Follow-up study finding suboptimal progression-free survival using reduced dose radiation in patients with medulloblastoma.
  • Evans A, Jenkin R, Sposto R et al The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. I Neurosurg: 72, 572–582 (1990).
  • Packer R, Sutton L, Elterman R et al Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. I Neumsurg: 81, 690–698 (1994).
  • Kalifa C, Valteau D, Pizer B et al High-dose chemotherapy in childhood brain tumours. Child. Nerv Syst. 15, 498–505 (1999).
  • Geyer J, Zeltzer P, Boyett J et al Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J. Clin. Oncol. 12, 1607–1615 (1994).
  • Dupuis-Girod S, Hartmann 0, Benhamou E et &Will high-dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? Neuro-Oncol. 27, 87–98 (1996).
  • Chintagumpala M, Berg S, Blaney S. Treatment controversies in medulloblastoma. Curl: Opin. Oncol. 13, 154–159 (2001).
  • Gajjar A, Mulhern R, Heideman R et al Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J. Clin. Oncol. 12, 1212–1216 (1994).
  • Fisher P, Needle M, Cnaan A et al. Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children. Cancer83, 566–574 (1998).
  • Sheurlen W, Schwabe G, Joos S et al Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with a poor outcome. J. Clin. Oncol 16, 2478–2485 (1998).
  • Grotzer M, Janss A, Fung K-M et al TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J. Clin. Oncol. 18, 1027–1035 (2000).
  • Duncan J, Hoffman H. Intracranial ependymomas. In: Brain TU117013: Kaye A, Lows E (Ed). Churchill Livingstone, Edinburgh, UK, 493–504 (1995).
  • Evans A, Anderson J, Lefkowitz-Boudreauz I et al Adjuvant chemotherapy of childhood posterior fossa ependymomas: craniospinal irradiation with or without adjuvant CCNU, vincristine and prednisone: a Children's Cancer Group study. Med. Pecliah: Onto]: 27, 8–14 (1996).
  • Merchant T Current management of childhood ependymoma. Oncology16, 629–644 (2002).
  • Robertson P, Zeltzer P, Boyett J et al Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. I Neurosurg: 88, 695–703 (1998).
  • Duffner P, Krischer J, Sanford R et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pecliah: Neurosurg. 28, 215–222 (1998).
  • Horn B, Heideman R, Geyer J et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J. Fed. Remota]: Oncol. 21, 203–211 (1999).
  • Pollack I, Gerszten P, Martinez A et al. Intracranial ependymomas of childhood: longterm outcome and prognostic factors. Neurosurgery 37, 655–666 (1995).
  • Mork S, Loken S. Ependymoma: a follow- up study of 101 cases. Cancer 40, 907–915 (1977).
  • Shuman R, Alvord E, Leech R. The biology of childhood ependymomas. Arch. Neural. 32, 731–739 (1975).
  • Hukin J, Epstein F, Lefton D et al Treatment of intracranial ependymoma by surgery alone. Pecliah: Neurosurg: 29, 40–45 (1998).
  • Palma L, Celli P, Mariottini A et al The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Child. Nerv. Syst. 16, 170–175 (2000).
  • Grill J, Le Deley M-C, Gambarelli D etal. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J. Clin. Oncol. 19, 1288–1296 (2001).
  • Boyd M, Steinbok P Choroid plexus tumors: problems in diagnosis and management. Neurosurg 66, 800–805 (1987).
  • Chin C, Dillon W Magnetic resonance imaging of central nervous system tumors. In: Brain Cancer Prados M (Ed.). BC Decker Hamilton, ON, Canada 104–127 (2002).
  • Pencalet P, Sainte-Rose C, Lellouch-Tubiana A et al Papillomas and carcinomas of the choroid plexus in children. J. Neurosurg. 88, 521–528 (1998).
  • Wolff J, Sajedi M, Coppes M, Anderson R, Egeler R. Radiation therapy and survival in choroid plexus carcinoma. Lancet 353, 2126 (1999).
  • Duffner P, Kun L, Burger P et al Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. Pediatr. Neurosurg: 22, 189–196 (1995).
  • Berger C, Thiesse P, Lellouch-Tubiana A et al Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurge 0,42, 470 (1998).
  • St. Clair S, Humphreys R, Pillay P et al Current management of choroid plexus carcinoma in children. Pecliatr Neurosurg: 17, 225–233 (1992).
  • Allen J, Wisoff J, Helson L et al Choroid plexus carcinoma — responses to chemotherapy alone in newly diagnosed young children. J. Neuro—Oncol. 12, 69–74 (1992).
  • Mallucci C, Lellouch-Tubiana A, Salazar C et al The management of desmoplastic neuroepithelial tumours in childhood. Child. Nerv. Syst. 16, 8–14 (2000).
  • Yachnis A. Neuropathology of pediatric brain tumors. Sem. Fed. Neural. 4,282–291 (1997).
  • Rorke L, Packer R, Biegel J. Central nervous system atypical teratoicilrhabdoid tumors of infancy and childhood: definition of an entity. I Neurosurg: 85, 56–65 (1996).
  • •Classic paper with inital description and definition of atypical teratoid/ rhabdoid tumors.
  • Packer R, Biegel J, Blaney S et al Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. j Pad. Hematol Oncol 24, 337–342 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.